In association with

Maximising

manufacturing

How can companies overcome the  manufacturing challenges hindering the revolutionary potential of gene and cell therapies?

ISSUE 75 I OCTOBER 2018

Making the most of biomarkers

Clinical trial transparency in the Americas

AI generated compounds
11/26/2018 12:12:39
  • Home | Maximising Manufacturing
  • Editorial
  • Pfanstiehl Company Insight
  • Pfanstiehl
  • Contents
  • Daiichi Jitsugyo
  • Medelpharm
  • News
  • B & W Tek
  • The Pharma Industry Briefing
  • Clinical trial transparency in the Americas
  • Malvern Panalytical Company Insight
  • Malvern Panalytical
  • Aralab
  • Gene and cell therapies: making manufacturing work
  • Capsugel Company Insight
  • Abiogen Pharma
  • Amazon and PillPack: an unstoppable pharmacy force?
  • Gerresheimer
  • SGS
  • Cancer trials: making the most of biomarkers
  • SmartCAE Company Insight
  • SmartCAE
  • The highs and lows of hormone replacement therapy
  • Ecocool
  • Lauda
  • Verge Genomics: employing AI to improve drug discovery
  • AirBridgeCargo Company Insight
  • AirBridgeCargo
  • Senn Chemicals
  • What can life sciences firms really achieve with AI?
  • Pall Biotech
  • CBDepot
  • G.F.
  • Setting practical parameters for more accurate regulatory resourcing
  • TSS AB
  • Masterpack
  • HOF Sonderanlagenbau
  • Röchling Medical Neuhaus
  • Cannabis branding: Marketing an industry from the ground up
  • Alpex
  • Pharmasol
  • Events
  • AECO Telecom & Security Systems
  • Event: CPhI Worldwide
  • HTI Plastics
  • Sanofi
  • Event: Outsourcing in Clinical Trials DACH 2018
  • Procaps Company Insight
  • Procaps
  • Event: Big Data & Analytics for Pharma Summit
  • Wilhelm Haselmeier GmbH & Co KG Company Insight
  • Wilhelm Haselmeier GmbH & Co. KG
  • Next issue
  • Scandinavian Health Ltd. Company Insight
  • Scandinavian Health Ltd.
  • ILC Dover Inc
  • Scilabware